NYMOX PHARMACEUTICAL CORP (NYMX)

BSP733981026 - Common Stock

0.2  -0.05 (-19.68%)

After market: 0.1767 -0.02 (-11.65%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-3-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.0010.00K120.00K
Cost Of Goods
N/AN/A0.000.0060.00K
Gross Profit
N/AN/A0.000.0060.00K
Operating Expenses
2.96M6.65M12.50M11.73M13.38M
Research and Development
159.00K3.77M6.66M8.11M7.37M
Selling, General, and Administrative Expenses
2.80M2.88M5.85M3.60M6.01M
Operating Income
-2.96M-6.65M-12.50M-11.72M-13.33M
Interest Income/Expense
-27.00K-37.00K-33.00K-20.00K160.00K
Other Income/Expense
N/A113.00KN/AN/A0.00
Income Before Taxes
-2.88M-6.58M-12.54M-11.74M-13.16M
Income Tax
0.000.000.000.000.00
Net Income
-2.88M-6.58M-12.54M-11.74M-13.16M
EBITDA
-2.95M-6.64M-12.49M-11.71M-13.32M
 
Per Share Data
EPS Diluted Total Ops
-0.03-0.07-0.15-0.16-0.19
 
Statistics
Gross Profit Margin
N/AN/AN/AN/A50.00%
Profit Margin
N/AN/AN/A-117400.00%-10966.67%
Operating Profit Margin
N/AN/AN/A-117200.00%-11108.33%

All data in USD

Charts